Leroux-Roels G - Search Results

1

The interferon gamma secretion assay: a reliable tool to study interferon gamma production at the single cell level.

Desombere I, Meuleman P, Rigole H, Willems A, Irsch J, Leroux-Roels G. Desombere I, et al. J Immunol Methods. 2004 Mar;286(1-2):167-85. doi: 10.1016/j.jim.2004.01.001. J Immunol Methods. 2004. PMID: 15087231

2

Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes.

Desombere I, Hauser P, Rossau R, Paradijs J, Leroux-Roels G. Desombere I, et al. J Immunol. 1995 Jan 15;154(2):520-9. J Immunol. 1995. PMID: 7814865

3

Haptoglobin polymorphism and the immune response after hepatitis B vaccination.

Louagie H, Delanghe J, Desombere I, De Buyzere M, Hauser P, Leroux-Roels G. Louagie H, et al. Vaccine. 1993 Sep;11(12):1188-90. doi: 10.1016/0264-410x(93)90041-u. Vaccine. 1993. PMID: 8256500 Clinical Trial.

4

Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa.

Leroux-Roels G, Esquivel CA, DeLeys R, Stuyver L, Elewaut A, Philippé J, Desombere I, Paradijs J, Maertens G. Leroux-Roels G, et al. Hepatology. 1996 Jan;23(1):8-16. doi: 10.1002/hep.510230102. Hepatology. 1996. PMID: 8550052 Clinical Trial.

5

Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young healthy adults.

Leroux-Roels G, Moreau W, Desombere I, Safary A. Leroux-Roels G, et al. Scand J Gastroenterol. 1996 Oct;31(10):1027-31. doi: 10.3109/00365529609003124. Scand J Gastroenterol. 1996. PMID: 8898425 Clinical Trial.

6

In vitro TNF-alpha, IL-2 and IFN-gamma production as markers of relapses in multiple sclerosis.

Philippé J, Debruyne J, Leroux-Roels G, Willems A, Dereuck J. Philippé J, et al. Clin Neurol Neurosurg. 1996 Nov;98(4):286-90. doi: 10.1016/0303-8467(96)00041-8. Clin Neurol Neurosurg. 1996. PMID: 8930418

7

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults.

Leroux-Roels G, Desombere I, De Tollenaere G, Petit MA, Desmons P, Hauser P, Delem A, De Grave D, Safary A. Leroux-Roels G, et al. Vaccine. 1997 Nov;15(16):1724-31. doi: 10.1016/s0264-410x(97)00117-5. Vaccine. 1997. PMID: 9364674 Clinical Trial.

8

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines.

Leroux-Roels G, Desombere I, Cobbaut L, Petit MA, Desmons P, Hauser P, Delem A, De Grave D, Safary A. Leroux-Roels G, et al. Vaccine. 1997 Nov;15(16):1732-6. doi: 10.1016/s0264-410x(97)00118-7. Vaccine. 1997. PMID: 9364675 Clinical Trial.

9

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system.

Thoelen S, Van Damme P, Mathei C, Leroux-Roels G, Desombere I, Safary A, Vandepapeliere P, Slaoui M, Meheus A. Thoelen S, et al. Vaccine. 1998 Apr;16(7):708-14. doi: 10.1016/s0264-410x(97)00254-5. Vaccine. 1998. PMID: 9562690 Clinical Trial.

10

Response to hepatitis B vaccine: multiple HLA genes are involved.

Desombere I, Willems A, Leroux-Roels G. Desombere I, et al. Tissue Antigens. 1998 Jun;51(6):593-604. doi: 10.1111/j.1399-0039.1998.tb03001.x. Tissue Antigens. 1998. PMID: 9694351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters